Kim SI, Joung JG, Kim YN, Park J, et al. Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial. Gynecol Oncol 2024;182:7-14.
PMID: 38246047